A. Corcuera

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

C. Brander, V. Miller, T. Peto, 2021, Cell reports.

Idiopathic pylephlebitis and idiopathic sclerosing peritonitis in a man with protein S deficiency.

E. Musulen, X. Calvet, A. Malet, 2001, Journal of clinical gastroenterology.

Direct‐Acting Antivirals for the Treatment of Chronic Hepatitis B Virus (HBV) Infection

Andreas Urban, A. Corcuera, A. Donald, 2021, New Drug Development for Known and Emerging Viruses.

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators.

M. Kielpinski, T. Henkel, E. Alza, 2021, Analytical methods : advancing methods and applications.

Novel non‐heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro

R. Bartenschlager, Ji-Young Lee, A. Birkmann, 2018, Antiviral research.

Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators.

P. A. Pushkarev, Mauro Fianchini, Anton A. Homon, 2023, Bioorganic & medicinal chemistry letters.

Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses

C. Brander, V. Miller, T. Peto, 2020, SSRN Electronic Journal.